US Market Report for Neurovascular Stents 2017 - MedCore
High single digit market growth will be seen throughout the forecast period for neurovascular stents as next generation devices continue to enter the U.S. market. Traditional coil assisted stenting will continue to grow in unit sales while flow diversion stenting, a new and promising endovascular treatment, will experience rapid growth as well. Sales of these devices in the U.S. only began in 2011 following the approval of the Pipeline™ device from Medtronic. Flow diversion stents have the potential to cannibalize a portion of traditional stent sales but they will both continue to experience growth. These increases in unit sales will also be driven by innovation in these devices making them smaller and able to place in more distal locations. The high market value is in part attributable to the fact that flow diversion stents command an ASP of nearly twice that of a traditional stent. Both types of stents are expected to experience marginal increases in pricing due to innovation, which will also drive market growth.
There are two main types of neurovascular stents currently on the market, the traditional stent and the flow diverter stent. They are both used as treatments for cerebral aneurysms. Traditional neurovascular stents are small, flexible, tube-like devices used for stabilizing detachable coils within an aneurysm. They serve to block off the aneurysm and to prevent coils from slipping back into the main blood vessel. These stents are also used to treat intracranial stenosis by opening blocked arteries. These stents are delivered in reduced tube structures for easier navigation and delivery through the narrow intracranial vessels. As brain arteries are more fragile than carotid arteries, a self-expanding stent that gently opens to the desired vessel diameter is generally used. Self-expandable stents carry a lower risk of dissection or vessel rupture when compared to the balloon-expandable stents.
- EXECUTIVE SUMMARY
- U.S. NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW
- COMPETITIVE ANALYSIS
- MARKET TRENDS
- MARKET DEVELOPMENTS
- PROCEDURE NUMBERS
- PROCEDURE CODES INVESTIGATED
- MARKETS INCLUDED
- KEY REPORT UPDATES
- VERSION HISTORY
- RESEARCH METHODOLOGY
- 1.1 RESEARCH SCOPE
- 1.2 IDATA’S 9-STEP METHODOLOGY
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast and Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
- DISEASE OVERVIEW
- 2.1 BASIC ANATOMY
- 2.2 DISEASE PATHOLOGY AND DISORDERS
- 2.2.1 Introduction
- 2.2.2 General Diagnostics and Neurosurgery
- 2.2.3 Tumor and Brain Cancer
- 2.2.4 Brain Arteriovenous Malformations
- 2.2.5 Ischemic Stroke
- 2.2.6 Brain Aneurysm
- 2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure
- 2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder
- 2.2.7.2 Cerebral Edema
- 2.2.8 Indication for Neuromodulation
- 2.2.9 Traumatic brain injury
- PRODUCT ASSESSMENT
- 3.1 PRODUCT PORTFOLIOS
- 3.1.1 Neurovascular Stent
- 3.1.1.1 Introduction
- 3.1.1.2 Product Matrix for Neurovascular Stent Market: Core Companies
- 3.2 REGULATORY ISSUES AND RECALLS
- 3.2.1 Neurovascular Stent
- 3.3 CLINICAL TRIALS
- 3.3.1 Neurovascular Stent
- NEUROVASCULAR STENT MARKET
- 4.1 INTRODUCTION
- 4.2 MARKET OVERVIEW
- 4.3 MARKET ANALYSIS AND FORECAST
- 4.3.1 Total Neurovascular Stent Market
- 4.3.2 Traditional Neurovascular Stent Market
- 4.3.3 Flow Diversion Stent Market
- 4.4 DRIVERS AND LIMITERS
- 4.4.1 Market Drivers
- 4.4.2 Market Limiters
- 4.5 COMPETITIVE MARKET SHARE ANALYSIS
- ABBREVIATIONS
- APPENDIX: COMPANY PRESS RELEASES
- List of Charts
- Chart 1 1: Neurological Device Market by Segment, U.S., 2013 – 2023
- Chart 1 2: Neurological Device Market Overview, U.S., 2016 & 2023
- Chart 4 1: Neurovascular Stent Market, U.S., 2013 – 2023
- Chart 4 2: Neurovascular Stent Market Breakdown, U.S., 2016
- Chart 4 3: Neurovascular Stent Market Breakdown, U.S., 2023
- Chart 4 4: Total Neurovascular Stent Market, U.S., 2013 – 2023
- Chart 4 5: Traditional Neurovascular Stent Market, U.S., 2013 – 2023
- Chart 4 6: Flow Diversion Stent Market, U.S., 2013 – 2023
- Chart 4 7: Leading Competitors, Neurovascular Stent Market, U.S., 2016
- List of Figures
- Figure 1 1: Neurological Device Market Share Ranking by Segment, U.S., 2016 (1 of 3)
- Figure 1 2: Neurological Device Market Share Ranking by Segment, U.S., 2016 (2 of 3)
- Figure 1 3: Neurological Device Market Share Ranking by Segment, U.S., 2016 (3 of 3)
- Figure 1 4: Companies Researched in this Report, U.S., 2016
- Figure 1 5: Factors Impacting the Neurological Device Market by Segment, U.S. (1 of 3)
- Figure 1 6: Factors Impacting the Neurological Device Market by Segment, U.S. (2 of 3)
- Figure 1 7: Factors Impacting the Neurological Device Market by Segment, U.S. (3 of 3)
- Figure 1 8: Recent Events in the Neurological Device Market, U.S., 2014 – 2016
- Figure 1 9: Neurological Device Markets Covered, U.S., 2016
- Figure 1 10: Procedural Codes Investigated, U.S., 2016 (1 of 2)
- Figure 1 11: Procedural Codes Investigated, U.S., 2016 (2 of 2)
- Figure 1 12: Neurological Device Markets Covered, U.S., 2016 (1 of 2)
- Figure 1 13: Neurological Device Markets Covered, U.S., 2016 (2 of 2)
- Figure 1 14: Key Report Updates
- Figure 1 15: Version History
- Figure 2 1: Neurology Disease Overview
- Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016
- Figure 3 1: Class 2 Device Recall: Pipeline and Pipeline Flex
- Figure 3 2: Class 2 Device Recall: Stryker brand Neuroform 3 Microdelivery Stent System
- Figure 3 3: Class 2 Device Recall: Wingspan Stent System
- Figure 3 4: Neurovascular Stent: Safety and Effectiveness of an Intracranial Aneurysm Embolization System
- Figure 3 5: Neurovascular Stent: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device (VRD)
- Figure 3 6: Neurovascular Stent: Flow Diverter Stent for Endovascular Treatment of Unruptured Saccular Wide-necked Intracranial Aneurysms (EVIDENCE)
- Figure 3 7: Neurovascular Stent: Complete Occlusion of Coilable Aneurysms (COCOA)
- Figure 3 8: Neurovasculr Stents: VISSIT Intracranial Stent Study for Ischemic Therapy (VISSIT)
- Figure 3 9: Neurovasculr Stents: The Registry to Study Safety and Performance of the CORDIS Vascular Reconstruction Device and Delivery System (SUNRISE)
- Figure 3 10: Neurovasculr Stents: Enterprise Stent Aneurysm Treatment (ESAT) Study - France (ESAT)
- Figure 4 1: Neurovascular Stent Market, U.S., 2013 – 2023 (US$M)
- Figure 4 2: Total Neurovascular Stent Market, U.S., 2013 – 2023
- Figure 4 3: Traditional Neurovascular Stent Market, U.S., 2013 – 2023
- Figure 4 4: Flow Diversion Stent Market, U.S., 2013 – 2023
- Figure 4 5: Drivers and Limiters, Neurovascular Stent Market, U.S., 2016
- Figure 4 6: Leading Competitors, Neurovascular Stent Market, U.S., 2016
- Figure 6 1: Press Release Summary
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook